Effectiveness and safety of levofloxacin for multidrug resistant pulmonary tuberculosis: A systematic review

Chinese Journal of Evidence-Based Medicine

Volumn 12, Issue 2, 2012, Pages 201-208

  Zhu, Hang ^a   Lei, Xun ^a   Zhang, Fan ^a   Zhang, Zhi Jiao ^a   Lu, Jia ^a   Li, Hui ^a   Wang, Yang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Levofloxacin; Meta analysis; Multidrug resistant pulmonary tuberculosis; Pulmonary tuberculosis; Randomized controlled trial; Systematic review

Indexed keywords

ETHAMBUTOL; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PLACEBO; STREPTOMYCIN;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; HUMAN; META ANALYSIS; MULTIDRUG RESISTANT TUBERCULOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPUTUM; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 84859983088     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. World Health Organization. Stop TB Dept. Global tuberculosis control: surveillance, planning, financing: WHO report 2007. http://www.who.int/tb/publications/globalreport/2007/downloadcentre/index.html. Accessed Mar 2010
2. Chinese source.
3. Chinese source.
4. Chinese source.
5. Chinese source.
6. Chinese source.
7. Chinese source.
8. Chinese source.
9. Chinese source.
10. Chinese source.
11. Chinese source.
12. Chinese source.
13. Chinese source.
14. Chinese source.
15. Chinese source.
16. Chinese source.
17. Chinese source.
18. Chinese source.
19. Chinese source.
20. Chinese source.
21. Chinese source.
22. Chinese source.
23. Chinese source.
24. Chinese source.
25. Chinese source.
26. Chinese source.
27. Chinese source.
28. Chinese source.
29. Chinese source.
30. Chinese source.
31. Chinese source.
32. Chinese source.
33. Chinese source.
34. Chinese source.
35. Chinese source.
36. Chinese source.
37. Chinese source.
38. El-Sadr WM, Perlman DC, Matts JP, et al. Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG). Clinical Infectious Disease, 1998, 26(5): 1148-1158.
39. Chinese source.